PDK4 and immune system disorder: Myocardial ischemia-reperfusion injury can be alleviated through overexpression of miR-148, ultimately improving myocardial antioxidant levels, alleviating myocardial apoptosis and immune dysfunction, and mitigating myocardial dysfunction via PDK4 inhibition [52].